FDA Clears OncoSil Device for Advanced Bile Duct Cancer

The FDA has approved OncoSil Medical's OncoSil device, a targeted radiation treatment for adults with unresectable, non-metastatic distal cholangiocarcinoma. This approval marks a significant regulatory milestone, providing the first and only Class III device for this rare and aggressive cancer in the U.S. market, to be used alongside systemic therapy.